Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for July 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Biologic Tx for Psoriasis May Reduce Coronary Inflammation
WEDNESDAY, July 31, 2019 (HealthDay News) — For patients with moderate-to-severe psoriasis, the perivascular fat attenuation index (FAI), as measured by coronary computed tomography angiography (CCTA), indicates reduced coronary inflammation in association with biologic therapy, according to a study published online July 31 in JAMA Cardiology.
Abstract/Full Text (subscription or payment may be required)
Risk for Allergy Development Increased After Gastric Acid Inhibitor Use
WEDNESDAY, July 31, 2019 (HealthDay News) — Patients receiving gastric acid inhibitors have an increase in prescriptions of anti-allergic drugs, according to a study published online July 30 in Nature Communications.
Oral Semaglutide Reduces HbA1c, Weight in Patients With T2DM
WEDNESDAY, July 31, 2019 (HealthDay News) — Compared with placebo, oral semaglutide monotherapy is associated with superior and clinically relevant improvements in glycated hemoglobin (HbA1c) and weight loss among patients with type 2 diabetes, according to a study published online July 18 in Diabetes Care.
Abstract/Full Text (subscription or payment may be required)
$70 Million Settlement Reached in Generic Drug Delay Case
TUESDAY, July 30, 2019 (HealthDay News) — Three drug companies will pay a total of nearly $70 million to California to settle charges of delaying the sale of generic drugs to keep brand-name drug prices high, the state’s attorney general said Monday.
New Opioid Rx Rules Coming for U.S. Employees’ Health Plans
TUESDAY, July 30, 2019 (HealthDay News) — Tighter rules on opioid painkiller prescriptions for U.S. government employees will be implemented in the fall, the Trump Administration says.
Work-Related Injuries Up Suicide and Drug-Related Death
TUESDAY, July 30, 2019 (HealthDay News) — Workplace injuries severe enough to warrant more than a week away from work may increase the risk for death among workers, according to a study published online July 12 in the American Journal of Industrial Medicine.
Abstract/Full Text (subscription or payment may be required)
SGLT-2 Inhibitor Use Not Linked to Increased Risk for UTI Events
TUESDAY, July 30, 2019 (HealthDay News) — Initiation of therapy with sodium-glucose cotransporter-2 (SGLT-2) inhibitors for type 2 diabetes mellitus is not associated with an increased risk for urinary tract infection (UTI) events compared with initiation of other second-line antidiabetic medications, according to a study published online July 30 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Lifesaving Drug for Infants Costs $2.1 Million a Dose
MONDAY, July 29, 2019 (HealthDay News) — Its extremely high price tag means that a lifesaving medication to treat young children with spinal muscular atrophy is simply too expensive for most families.
Serious Falls Pose Risk to People Living With HIV
MONDAY, July 29, 2019 (HealthDay News) — Benzodiazepines and muscle relaxants are associated with serious falls among people living with HIV in their 50s, according to a study recently published in the Journal of Acquired Immune Deficiency Syndrome.
Abstract/Full Text (subscription or payment may be required)
Opioid Prescribing, New Persistent Use Down After Childbirth
MONDAY, July 29, 2019 (HealthDay News) — Since 2008, there has been a decrease in opioid prescribing and new persistent use after vaginal or cesarean delivery, according to a study published online July 26 in JAMA Network Open.
FDA: Blood Clot, Death Risk Up With Higher Dose of Tofacitinib
FRIDAY, July 26, 2019 (HealthDay News) — New warnings about an increased risk of thrombosis and of death among ulcerative colitis patients taking the 10 mg twice daily dose of the drug tofacitinib (Xeljanz, Xeljanz XR) have been issued by the U.S. Food and Drug Administration.
Testosterone Replacement Therapy May Increase Cardiovascular Risk
FRIDAY, July 26, 2019 (HealthDay News) — For aging men with low testosterone levels, testosterone replacement therapy (TRT) may increase the risk of cardiovascular events, especially in the first two years of use, according to a study published in the September issue of The American Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Some Men at Risk for HIV Do Not Live Near PrEP Provider
FRIDAY, July 26, 2019 (HealthDay News) — A considerable proportion of men who have sex with men (MSM), who are eligible for HIV preexposure prophylaxis (PrEP), live in locations with no nearby PrEP provider, according to a study published online July 18 in the American Journal of Public Health.
Abstract/Full Text (subscription or payment may be required)
Review Supports Testosterone for Low Sexual Desire in Women
FRIDAY, July 26, 2019 (HealthDay News) — For postmenopausal women with low sexual desire causing distress, testosterone is an effective treatment, with a preference for nonoral administration, according to a review published online July 25 in the The Lancet Diabetes & Endocrinology.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Vitamin D Supplementation Beneficial for Glucose Metabolism
FRIDAY, July 26, 2019 (HealthDay News) — Vitamin D3 supplementation can improve glucose metabolism in patients at high risk of diabetes or with newly-diagnosed diabetes, according to a study published online July 1 in the European Journal of Endocrinology.
Roxadustat Noninferior to Epoetin Alfa in Dialysis Patients
FRIDAY, July 26, 2019 (HealthDay News) — Roxadustat is noninferior to epoetin alfa for increasing hemoglobin levels among patients with anemia who are undergoing dialysis, and is superior to placebo for patients not undergoing dialysis, according to two studies published in the July 24 issue of the New England Journal of Medicine.
Abstract/Full Text 1 (subscription or payment may be required)
Abstract/Full Text 2 (subscription or payment may be required)
Editorial (subscription or payment may be required)
Minor Changes in BMD Seen With Tenofovir PrEP in Short Term
THURSDAY, July 25, 2019 (HealthDay News) — Tenofovir preexposure prophylaxis (PrEP) therapy does not appear to be associated with clinically significant declines in bone mineral density (BMD) in the short term, according to a study published online June 19 in AIDS Research and Human Retroviruses.
Targeted Interventions Raise HPV Vaccine Acceptance in Women
THURSDAY, July 25, 2019 (HealthDay News) — Among young women, targeted educational interventions, particularly educational videos, increase human papillomavirus (HPV) vaccine acceptability and knowledge, according to a study published online July 9 in Obstetrics & Gynecology.
Abstract/Full Text Editorial (subscription or payment may be required)
FDA Warns CBD Product Maker About False Claims
WEDNESDAY, July 24, 2019 (HealthDay News) — A warning letter has been issued to Massachusetts-based Curaleaf Inc. for illegally selling unapproved cannabidiol (CBD) products online with unproven claims that the products treat cancer, Alzheimer disease, opioid withdrawal, pain, and other health problems, the U.S. Food and Drug Administration says.
WHO ‘Treat All’ Recommendation for HIV Widely Implemented
WEDNESDAY, July 24, 2019 (HealthDay News) — The World Health Organization “Treat All” strategy for antiretroviral treatment (ART) initiation among patients living with HIV was the standard of care at almost all International epidemiology Databases to Evaluate AIDS (IeDEA) sites by mid-2017, according to a study published in the July issue of the Journal of the International AIDS Society.
Periop Diabetic Ketoacidosis Seen in Patients on SGLT2 Inhibitors
WEDNESDAY, July 24, 2019 (HealthDay News) — Sodium-glucose cotransporter-2 inhibitor (SGLT2i)-associated diabetic ketoacidosis (DKA) may occur after surgery even in patients with normal or near-normal blood glucose levels, according to a review published in the July issue of the British Journal of Anaesthesia.
Metformin May Lower Dementia Risk in Black Patients With T2DM
WEDNESDAY, July 24, 2019 (HealthDay News) — Metformin use is associated with a substantially lower risk for dementia among younger African-American patients with diabetes compared with sulfonylurea initiation, according to a study published in the July/August issue of the Annals of Family Medicine.
Filgotinib Bests Placebo in Tx of Refractory Rheumatoid Arthritis
TUESDAY, July 23, 2019 (HealthDay News) — Among patients with moderately to severely active rheumatoid arthritis (RA) resistant to previous therapy with biologic agents, a significantly higher clinical response rate was seen at 12 weeks for those receiving filgotinib versus placebo, according to a study published in the July 23/30 issue of the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Senate Bill Would Reduce Drug Costs for Seniors
TUESDAY, July 23, 2019 (HealthDay News) — A bill to reduce prescription drug costs for millions of Medicare recipients and lower federal and state health costs has been introduced by two U.S. senators.
CV Event Risk Up With Rejected, Abandoned PCSK9i Prescriptions
TUESDAY, July 23, 2019 (HealthDay News) — Patients with rejected or abandoned prescriptions for proprotein convertase subtilisin kexin type 9 inhibitors (PCSK9i) have a significantly increased risk for cardiovascular events than those with paid prescriptions, according to a study published online July 23 in Circulation: Cardiovascular Quality and Outcomes.
Stimulant Treatment Has Strong Protective Effect in ADHD
TUESDAY, July 23, 2019 (HealthDay News) — For youth with attention-deficit/hyperactivity disorder (ADHD), stimulants have strong protective effects on functional outcomes, according to a study published online July 23 in the Journal of Adolescent Health.
T2DM Increases Gastric Cancer Risk After H. Pylori Eradication
TUESDAY, July 23, 2019 (HealthDay News) — Type 2 diabetes mellitus increases the risk for gastric cancer after treatment for Helicobacter pylori infection, according to a study published online July 11 in Diabetes Care.
Abstract/Full Text (subscription or payment may be required)
Nonprescription Antibiotic Use Seems Prevalent in the United States
MONDAY, July 22, 2019 (HealthDay News) — Nonprescription antibiotic use appears to be prevalent in the United States, according to a review published online July 23 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Almost One in Four Adults ≥40 Takes Aspirin for CVD Prevention
MONDAY, July 22, 2019 (HealthDay News) — Nearly 30 million U.S. adults aged 40 years or older use aspirin to prevent cardiovascular disease (CVD), including 6.6 million without a physician’s recommendation, according to a research letter published online July 23 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Light Therapy May Prevent Oral Mucositis for Some in Cancer Tx
MONDAY, July 22, 2019 (HealthDay News) — Photobiomodulation (PBM), such as laser and other light therapies, is recommended for prevention of oral mucositis (OM) in specific populations of cancer patients, according to a review published online July 8 in Supportive Care in Cancer.
Abstract/Full Text (subscription or payment may be required)
Opioid Rx Education Insufficient for Plastic Surgery Trainees
MONDAY, July 22, 2019 (HealthDay News) — Only one-fourth of U.S. plastic surgery residents report receiving opioid-prescriber education, according to a study published in the July issue of Plastic and Reconstructive Surgery.
Abstract/Full Text (subscription or payment may be required)
EPA Will Not Ban Pesticide Linked to Brain Harm in Children
FRIDAY, July 19, 2019 (HealthDay News) — Even though the pesticide chlorpyrifos has been linked to brain harm in children, it will not be banned in the United States, the Environmental Protection Agency announced Thursday.
Recommendations Developed for Japanese Encephalitis Vaccine
FRIDAY, July 19, 2019 (HealthDay News) — In the July 19 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, recommendations are presented for use of the Japanese encephalitis (JE) vaccine.
Supply of Opioids Predicts Long-Term Use in Injured Workers
FRIDAY, July 19, 2019 (HealthDay News) — The number of days supplied of an initial opioid prescription is the strongest risk factor for developing long-term opioid use among previously opioid-free injured workers, according to a study published online July 17 in JAMA Network Open.
Key Cystic Fibrosis Pathogens Reduced With Ivacaftor Use
FRIDAY, July 19, 2019 (HealthDay News) — For patients with cystic fibrosis (CF), ivacaftor use is associated with a reduction in pathogens, including Pseudomonas aeruginosa, according to a study published online July 19 in the Annals of the American Thoracic Society.
Abstract/Full Text (subscription or payment may be required)
Current Antibiotic Stewardship Program Practices Characterized
FRIDAY, July 19, 2019 (HealthDay News) — Current infection prevention and antibiotic stewardship program practices continue to include a main focus on surveillance for multidrug-resistant organisms, according to a report published online July 17 in Infection Control & Hospital Epidemiology.
Abstract/Full Text (subscription or payment may be required)
Music Relieves Preop Anxiety Before Peripheral Nerve Block
FRIDAY, July 19, 2019 (HealthDay News) — Patients undergoing preoperative peripheral nerve block placement have a similar change in anxiolytic scores when they receive music medicine versus midazolam, according to a study published online July 18 in Regional Anesthesia & Pain Medicine.
Safety Practice Violations ID’d in Septic Arthritis Outbreak
THURSDAY, July 18, 2019 (HealthDay News) — Breaches of recommended infection prevention practices have been identified in an outbreak of septic arthritis cases after intra-articular injections performed in a private outpatient facility, according to a report published online July 17 in Infection Control & Hospital Epidemiology.
Abstract/Full Text (subscription or payment may be required)
Medical Marijuana Laws May Not Impact Opioid Use
THURSDAY, July 18, 2019 (HealthDay News) — Medical marijuana laws do not appear to impact nonmedical prescription opioid use or opioid use disorder, according to a study published online July 17 in JAMA Network Open.
Pregnancies in Women Taking Isotretinoin Dropped Since 2006
THURSDAY, July 18, 2019 (HealthDay News) — Since initiation of the iPLEDGE program in 2006 to reduce fetal exposure to isotretinoin, there has been a reduction in pregnancies among women taking isotretinoin, although exposure still persists, according to a report published online July 17 in JAMA Dermatology.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
About One in 20 Patients Exposed to Preventable Harm
THURSDAY, July 18, 2019 (HealthDay News) — The pooled prevalence of preventable patient harm is 6 percent across a range of medical settings globally, according to a review published online July 17 in The BMJ.
U.S. Drug OD Deaths Fall for First Time in Three Decades
WEDNESDAY, July 17, 2019 (HealthDay News) — For the first time in three decades, drug overdose deaths in the United States fell last year, preliminary federal government data suggest.
WHO Declares Congo Ebola Outbreak Global Health Emergency
WEDNESDAY, July 17, 2019 (HealthDay News) — The World Health Organization on Wednesday called the year-old outbreak of Ebola in the Democratic Republic of Congo a global health emergency, The New York Times reported.
The New York Times Article
More Information: WHO
Recarbrio OK’d for Complicated Urinary Tract, Intra-Abdominal Infections
WEDNESDAY, July 17, 2019 (HealthDay News) — The antibacterial drug product Recarbrio (imipenem, cilastatin, and relebactam) has been approved to treat complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI) in adults, the U.S. Food and Drug Administration announced today.
Menstrual Cups Seem Safe for Menstruation Management
WEDNESDAY, July 17, 2019 (HealthDay News) — Menstrual cups appear to be safe for menstruation management, according to a review published online July 16 in The Lancet Public Health.
Intranasal Sufentanil Cuts Acute Trauma Pain Treated in the ED
WEDNESDAY, July 17, 2019 (HealthDay News) — Intranasal sufentanil (INS) is comparable to intravenous morphine (IVM) for acute severe trauma pain treated in the emergency department, according to a study published online July 16 in PLOS Medicine.
Continuous Anticoagulants + Cold Snare Polypectomy Noninferior
WEDNESDAY, July 17, 2019 (HealthDay News) — For patients with subcentimeter colorectal polyps receiving oral anticoagulants, continuous administration of anticoagulants (CA) with cold snare polypectomy (CSP) is noninferior to periprocedural heparin bridging (HB) with hot snare polypectomy (HSP) for polypectomy-related major bleeding, according to a study published online July 16 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Rituximab Noninferior to Cyclosporine in Membranous Nephropathy
WEDNESDAY, July 17, 2019 (HealthDay News) — In patients with membranous nephropathy at high risk for progressive disease, rituximab is noninferior to cyclosporine in inducing complete or partial remission of proteinuria at 12 months and is superior in maintaining proteinuria remission up to 24 months, according to a study published in the July 4 issue of the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Extremely Low LDL Cholesterol May Up Stroke Risk
WEDNESDAY, July 17, 2019 (HealthDay News) — Cholesterol levels that are too low may increase the risk for hemorrhagic stroke, according to a study published online July 2 in Neurology.
Abstract/Full Text (subscription or payment may be required)
Many Patients With Depression Do Not Need a Psychiatrist
WEDNESDAY, July 16, 2019 (HealthDay News) — Primary care doctors can detect and treat most cases of depression, according to a study published in the July/August issue of the Annals of Family Medicine.
Educational Handout May Increase Receipt of Child Flu Shot
TUESDAY, July 16, 2019 (HealthDay News) — Providing an educational handout about influenza disease in the waiting room before a pediatric provider visit may increase receipt of child influenza vaccine, according to a study published online July 8 in Pediatrics.
Abstract/Full Text (subscription or payment may be required)
Alirocumab Cuts CV Absolute Risk the Most for Those With Diabetes
TUESDAY, July 16, 2019 (HealthDay News) — Among those receiving alirocumab in addition to statin therapy to reduce the risk for another cardiovascular event after a recent acute coronary syndrome, absolute risk reduction is greater for those with diabetes, according to a study published online July 1 in The Lancet Diabetes & Endocrinology.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Non-Vitamin K Oral Anticoagulants May Be Best for Early-Stage CKD
TUESDAY, July 16, 2019 (HealthDay News) — Non-vitamin K oral anticoagulants (NOACs) have a superior benefit-risk profile to that of vitamin K antagonists (VKAs) for patients with early-stage chronic kidney disease (CKD), according to a review published online July 16 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Congo Officials: First Ebola Case Confirmed in City of Goma
MONDAY, July 15, 2019 (HealthDay News) — The first case of Ebola in the city of Goma has been confirmed, Democratic Republic of Congo officials said Sunday.
Company Reaches $1.4 Billion Settlement in Opioid Treatment Investigation
MONDAY, July 15, 2019 (HealthDay News) — A drug company has reached a $1.4 billion settlement with the U.S. government over an investigation into the company’s marketing and sales of a prescription drug used to treat opioid addiction.
CNN Article
More Information: DOJ
Prepregnancy Surgery Linked to Risk for Neonatal Abstinence Syndrome
MONDAY, July 15, 2019 (HealthDay News) — Prepregnancy surgery is associated with elevated neonatal abstinence syndrome risk in future pregnancies, according to a study published in the July 15 issue of CMAJ, the journal of the Canadian Medical Association.
Opioids Commonly Prescribed in Emergency Department for Gout
MONDAY, July 15, 2019 (HealthDay News) — More than one-fourth of patients with acute gout discharged from the emergency department receive an opioid prescription, according to a study published online July 2 in Arthritis Care & Research.
Abstract/Full Text (subscription or payment may be required)
Etanercept Tx for Autoimmune Disease May Up Risk for IBD
MONDAY, July 15, 2019 (HealthDay News) — Patients with autoimmune diseases have an increased risk for being diagnosed with Crohn disease (CD) or ulcerative colitis (UC) while under treatment with etanercept, according to a study published online July 2 in Alimentary Pharmacology and Therapeutics.
Tool Uses Spine X-Rays to Assess Response to Osteoporosis Tx
MONDAY, July 15, 2019 (HealthDay News) — A new measure derived from conventional X-rays and a machine learning algorithm is effective for assessing bone-specific effects of osteoporosis treatment, according to a pilot study published in the July issue of Skeletal Radiology.
Prenatal Opioid Exposure Harms Long-Term Child Development
FRIDAY, July 12, 2019 (HealthDay News) — Prenatal opioid exposure (POE) is negatively associated with neurocognitive and physical development in offspring from the age of 6 months into school age, according to a study published online July 12 in JAMA Network Open.
Kratom Use Associated With Significant Toxicities
FRIDAY, July 12, 2019 (HealthDay News) — The unregulated herbal supplement known as kratom, which is mainly used for self-treating pain or mood disorders in the United States, is associated with significant toxicities, according to a report published in the July issue of Pharmacotherapy.
Abstract/Full Text (subscription or payment may be required)
U.S. Health, Economic Burden of Uncontrolled Asthma Projected
FRIDAY, July 12, 2019 (HealthDay News) — The economic burden of uncontrolled asthma is considerable and is projected to continue increasing, according to a study recently published in the American Journal of Respiratory and Critical Care Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Serious Misdiagnosis-Related Harms Mostly Due to ‘Big Three’
FRIDAY, July 12, 2019 (HealthDay News) — Vascular events, infections, and cancers account for about three-quarters of serious misdiagnosis-related harms, according to a study published online July 11 in Diagnosis.
CRP-Guided Testing Cuts Antibiotic Use in COPD Exacerbations
FRIDAY, July 12, 2019 (HealthDay News) — For patients with an acute exacerbation of chronic obstructive pulmonary disease (COPD), point-of-care testing of C-reactive protein (CRP) to guide antibiotic prescribing can reduce antibiotic use, according to a study published in the July 11 issue of the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Prescribing Fewer Tablets Can Cut Post-ACL Surgery Opioid Use
FRIDAY, July 12, 2019 (HealthDay News) — For patients undergoing anterior cruciate ligament reconstruction, prescribing fewer tablets is associated with lower postoperative opioid consumption, according to a research letter published in the June 25 issue of the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment may be required)
Uncontrolled Diabetes, Hypertension Rates High in CKD Patients
THURSDAY, July 11, 2019 (HealthDay News) — For patients with chronic kidney disease (CKD), the prevalence of uncontrolled hypertension and diabetes is high and has not improved over time, according to a study published online July 11 in the Clinical Journal of the American Society of Nephrology.
Abstract/Full Text (subscription or payment may be required)
Awareness, Use of PrEP on Rise Among Men Who Have Sex With Men
THURSDAY, July 11, 2019 (HealthDay News) — There has been a recent increase in the awareness and use of HIV preexposure prophylaxis (PrEP) among men who have sex with men (MSM), according to research published in the July 12 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Medicare Drug Rebate Plan Withdrawn by Trump Administration
THURSDAY, July 11, 2019 (HealthDay News) — A plan to let Medicare patients receive rebates that drug companies currently pay to insurers and middlemen has been withdrawn by the Trump administration.
Exposure to 2009 pH1N1 Vaccine During Pregnancy Seems Safe
THURSDAY, July 11, 2019 (HealthDay News) — Exposure to the 2009 pandemic H1N1 (pH1N1) influenza vaccine in pregnancy is not associated with most negative health outcomes among offspring, according to a study published online July 10 in The BMJ.
Abstract/Full Text
Editorial (subscription or payment may be required)
Rimegepant Shows Promise for Relief From Migraine Attacks
THURSDAY, July 11, 2019 (HealthDay News) — Compared with placebo, rimegepant, an orally administered, small-molecule, calcitonin gene-related peptide (CGRP) receptor antagonist, can increase the percentage of patients free of pain and free from their most bothersome symptom during a migraine attack, according to a study published in the July 11 issue of the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Hospitalized Pneumonia Patients Often Get Excess Antibiotics
THURSDAY, July 11, 2019 (HealthDay News) — Patients hospitalized with pneumonia often receive excess antibiotic therapy, according to a study published online July 9 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Oliceridine Studied for IV Pain Relief After Abdominoplasty
THURSDAY, July 11, 2019 (HealthDay News) — Oliceridine is being proposed as an analgesic option for the relief of moderate-to-severe acute postoperative pain, according to a study recently published in Pain Practice.
Health Care Professionals Exhibit Gender Bias
THURSDAY, July 11, 2019 (HealthDay News) — Survey results show that health care professionals have implicit and explicit gender bias, according to a study published online July 5 in JAMA Network Open.
Galcanezumab Can Cut Frequency of Cluster Headache Attacks
WEDNESDAY, July 10, 2019 (HealthDay News) — Galcanezumab can reduce the frequency of episodic cluster headache attacks, according to a study published in the July 11 issue of the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Lab Tests Show Experimental Ebola Treatments Effective
WEDNESDAY, July 10, 2019 (HealthDay News) — Two experimental Ebola treatments being used in the current outbreak in eastern Democratic Republic of the Congo have proved effective in laboratory tests with human cells, according to the U.S. Centers for Disease Control and Prevention. The study was published online July 9 in the The Lancet Infectious Diseases.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Press Release: CDC
Guidance Updated for Managing Infants at Risk for Group B Strep
WEDNESDAY, July 10, 2019 (HealthDay News) — Guidelines for the management and treatment of group B streptococcal (GBS) disease in infants were published online July 8 in Pediatrics.
Two Algorithms Can ID Patients at Risk for HIV, PrEP Candidates
WEDNESDAY, July 10, 2019 (HealthDay News) — Two new research papers, published online July 5 in The Lancet HIV, present algorithms that can help identify patients at risk for HIV and candidates for preexposure prophylaxis (PrEP).
Abstract/Full Text – Marcus (subscription or payment may be required)
Abstract/Full Text – Krakower (subscription or payment may be required)
Editorial (subscription or payment may be required)
About 12 Percent With Ankle Sprain Fill Opioid Prescriptions
WEDNESDAY, July 10, 2019 (HealthDay News) — Overall, 11.9 percent of patients diagnosed with an ankle sprain fill an opioid prescription within seven days of diagnosis, according to a research letter published online July 9 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Two-Dose Course of Vaccine After HSCT Cuts Incidence of Zoster
WEDNESDAY, July 10, 2019 (HealthDay News) — A two-dose course of recombinant zoster vaccine is associated with a reduction in the incidence of herpes zoster among adults who have undergone autologous hematopoietic stem cell transplantation (HSCT), according to a study published in the July 9 issue of the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment may be required)
High Incarceration Rates Tied to More Drug-Related Deaths
WEDNESDAY, July 10, 2019 (HealthDay News) — Reduced household income and high incarceration rates are associated with drug-related deaths, according to a study published in the July issue of The Lancet Public Health.
Abstract/Full Text
Editorial 1
Editorial 2
Xpovio With Dexamethasone Approved for Refractory Multiple Myeloma
TUESDAY, July 9, 2019 (HealthDay News) — Xpovio (selinexor) tablets have been approved for use in combination with dexamethasone to treat adults with relapsed refractory multiple myeloma, the U.S. Food and Drug Administration announced last week.
Rule Requiring Drug Prices in TV Ads Blocked by Judge
TUESDAY, July 9, 2019 (HealthDay News) — A Trump administration rule to force pharmaceutical companies to disclose the list prices of their drugs in television ads was blocked Monday by a federal judge.
Androgen Deprivation Therapy May Up Risk of Alzheimer Disease
TUESDAY, July 9, 2019 (HealthDay News) — Among elderly patients with prostate cancer, androgen deprivation therapy (ADT) exposure is associated with subsequent diagnosis of Alzheimer disease or dementia, according to a study published online July 3 in JAMA Network Open.
History of Liver Disease Does Not Impact Efficacy of Edoxaban
TUESDAY, July 9, 2019 (HealthDay News) — For patients with atrial fibrillation (AF), the efficacy and safety of edoxaban versus warfarin is not altered with a history of liver disease, according to a study published in the July 16 issue of the Journal of the American College of Cardiology.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Most Supplements Offer Little Protection Against Heart Disease
MONDAY, July 8, 2019 (HealthDay News) — Certain nutritional supplements and dietary interventions may reduce the risk for some cardiovascular outcomes in adults; however, the overall effect of nutritional supplements on cardiovascular disease outcomes remains unclear, according to a review published online July 9 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Eye Drops, Ointments Sold at Walgreens Recalled
MONDAY, July 8, 2019 (HealthDay News) — A number of over-the-counter eye products sold at Walgreens have been recalled by manufacturer Altaire Pharmaceuticals because the products may not be sterile.
Early Warning Signs May Predate Eating Disorder Onset
MONDAY, July 8, 2019 (HealthDay News) — Early warning signs may help providers identify eating disorders earlier, according to a study published online July 1 in the British Journal of Psychiatry.
Abstract/Full Text (subscription or payment may be required)
Survey Reveals Gaps in Opioid Rx Patterns of Orthopedic Surgeons
MONDAY, July 8, 2019 (HealthDay News) — The vast majority of orthopedic surgeons recommend prescribing a nine-day supply of around-the-clock oxycodone doses following commonly performed orthopedic surgeries, according to a study published in the May/June issue of the Journal of Opioid Management.
Abstract/Full Text (subscription or payment may be required)
Treating Depression May Reduce Mortality in Diabetes Patients
MONDAY, July 8, 2019 (HealthDay News) — The use of most types of antidepressants (ATDs) is associated with significantly reduced mortality among patients with diabetes mellitus (DM) and comorbid depression, according to a study published online July 2 in the Journal of Clinical Endocrinology & Metabolism.
Abstract/Full Text (subscription or payment may be required)
45 Percent of U.S. Adults Have Some Doubts About Vaccine Safety
MONDAY, July 8, 2019 (HealthDay News) — Just under half of U.S. adults have some doubts about vaccine safety, according to a survey released by the American Osteopathic Association.
Most Adult-Use Cannabis Customers Use for Pain, Sleep Relief
WEDNESDAY, July 3, 2019 (HealthDay News) — De facto medical use of cannabis for symptom relief is common among adult-use dispensary customers in Colorado, according to a study published online July 2 in the Journal of Psychoactive Drugs.
DOJ Asks Congress to Permanently Classify Fentanyl-Like Drugs
WEDNESDAY, July 3, 2019 (HealthDay News) — A temporary order classifying fentanyl-like drugs as controlled substances should be enacted into law, the U.S. Department of Justice is telling Congress.
Lack of Evidence for Treating Chronic Pain in Children
WEDNESDAY, July 3, 2019 (HealthDay News) — There is a lack of evidence on the efficacy and safety of pharmacological treatments for chronic pain in children, according to research published online June 19 in PAIN.
Abstract/Full Text (subscription or payment may be required)
Tanezumab Improves Scores for Pain, Function in Osteoarthritis
WEDNESDAY, July 3, 2019 (HealthDay News) — For patients with osteoarthritis (OA) of the knee or hip, tanezumab is associated with significant improvements in pain and physical function versus placebo, according to a study published in the July 2 issue of the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Interventions Linked to Drop in Unvaccinated Kindergartners
WEDNESDAY, July 3, 2019 (HealthDay News) — Statewide legislative and educational interventions are associated with a reduction in the yearly rates of kindergartners without up-to-date vaccination status, according to a study published in the July 2 issue of the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Most U.S. Adults Are Concerned About Antibiotic Resistance
WEDNESDAY, July 3, 2019 (HealthDay News) — Most U.S. adults have heard of and are concerned about antibiotic resistance, but 45 percent report having not taken antibiotics as prescribed, according to a report published online June 21 by the Kaiser Family Foundation.
Anti-Vaccine Movement a ‘Man-Made’ Health Crisis, Scientists Warn
TUESDAY, July 2, 2019 (HealthDay News) — The anti-vaccination movement is now a global crisis, an international panel of scientists say, and everyone must do more to combat it.
Press Release
The Salzburg Statement on Vaccination Acceptance
Statin Use Associated With Higher Incidence of Diabetes
TUESDAY, July 2, 2019 (HealthDay News) — There may be a dose-dependent relationship between statin therapy and new-onset diabetes across the duration of statin use, according to a study recently published in Diabetes Metabolism Research and Reviews.
Abstract/Full Text (subscription or payment may be required)
Guidance Issued for Management of Fontan Circulation
TUESDAY, July 2, 2019 (HealthDay News) — A scientific statement with recommendations for follow-up care in patients with Fontan circulation surviving into adulthood was published online July 1 in Circulation.
Abstract/Full Text (subscription or payment may be required)
In Utero Opioid Exposure Tied to Poor Outcomes Throughout Childhood
TUESDAY, July 2, 2019 (HealthDay News) — In utero exposure to opioids is associated with higher risks for short- and long-term adverse outcomes, including preterm birth and neurodevelopmental and physical health disorders in children, according to a study published online June 28 in JAMA Network Open.
Stewardship Intervention Can Cut Inappropriate Rx by a Third
MONDAY, July 1, 2019 (HealthDay News) — Antibiotic stewardship interventions for acute respiratory infection (ARI) can significantly reduce overuse in emergency departments and urgent care centers, according to a study published online June 19 in Academic Emergency Medicine.
Abstract/Full Text (subscription or payment may be required)
Metformin May Cut Mortality Risk in Post-Pancreatitis Diabetes
MONDAY, July 1, 2019 (HealthDay News) — Metformin use may promote a survival benefit in individuals with post-pancreatitis diabetes mellitus (PPDM), but not pancreatic cancer-related diabetes (PCRD), according to a study published online June 21 in Diabetes Care.
Abstract/Full Text (subscription or payment may be required)
Most Grandparents Store Meds in Containers That Are Easy to Open
MONDAY, July 1, 2019 (HealthDay News) — More than one in four grandparents report storing prescription medications in containers, primarily easy-to-open containers, according to a report published online July 1 by the National Poll on Healthy Aging.
Romosozumab Increases Bone Formation, Cuts Bone Resorption
MONDAY, July 1, 2019 (HealthDay News) — For postmenopausal women with osteoporosis, romosozumab increases bone formation and decreases bone resorption, according to a study published online June 24 in the Journal of Bone and Mineral Research.
Abstract/Full Text (subscription or payment may be required)
Copyright © 2019 ScoutNews, LLC. All rights reserved.
